Phage Therapy Brazil: Universities vs Superbugs | AcademicJobs
Explore how USP, Unifesp, and Unicamp drive fagoterapia research against superbactérias, from Cepid B3 to KIDNAP Study, amid Brazil's AMR crisis.
No reviews yet. Be the first to rate Shaker Chuck!
Shaker Chuck Farah is a Professor Titular in the Departamento de Bioquímica at the Instituto de Química of the Universidade de São Paulo. He earned a BSc in 1985 and an MSc in 1988 from the University of Toronto, followed by a PhD in Ciências Biológicas (Bioquímica) from the Universidade de São Paulo in 1994. He has served as a faculty member at the Universidade de São Paulo since 1996 and currently holds the position of Vice-Diretor of the Instituto de Química.
His research centers on the structural and functional biology of bacterial secretion systems and signaling pathways, using Xanthomonas citri as a primary model organism. Key areas include Type IV secretion systems involved in interbacterial competition, cyclic di-GMP signaling pathways regulating bacterial behaviors such as motility and biofilm formation, and Type IV pilus biogenesis and regulation. Representative publications include studies on bacteria-killing Type IV secretion systems published in Nature Microbiology (2018), Nature Communications (2015), and PLoS Pathogens (2020), among others. He has supervised numerous graduate students and postdoctoral researchers who have advanced to academic and research positions worldwide.
Explore how USP, Unifesp, and Unicamp drive fagoterapia research against superbactérias, from Cepid B3 to KIDNAP Study, amid Brazil's AMR crisis.